Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort

It is unclear whether in late life serum thyroid-stimulating hormone (TSH) predicts risk of developing cognitive impairment. This study investigated the prospective relationship of serum TSH with the risk of developing mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular demen...

Full description

Saved in:

Bibliographic Details
Published in:	Gerontology (Basel) Vol. 58; no. 1; p. 41
Main Authors:	Forti, Paola, Olivelli, Valentina, Rietti, Elisa, Maltoni, Benedetta, Pirazzoli, Gianluca, Gatti, Rita, Gioia, Maria Grazia, Ravaglia, Giovanni
Format:	Journal Article
Language:	English
Published:	Switzerland 01-01-2012
Subjects:	Aged Aged, 80 and over Aging - blood Aging - psychology Alzheimer Disease - blood Autoimmune Diseases - complications Biomarkers - blood Cognition Disorders - blood Cognition Disorders - etiology Cognitive Dysfunction - blood Cohort Studies Dementia, Vascular - blood Female Follow-Up Studies Humans Italy Male Predictive Value of Tests Risk Factors Thyroid Diseases - complications Thyrotropin - blood
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	It is unclear whether in late life serum thyroid-stimulating hormone (TSH) predicts risk of developing cognitive impairment. This study investigated the prospective relationship of serum TSH with the risk of developing mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular dementia (VaD) in an elderly cohort with a 4-year follow-up. Data are for 660 subjects aged 65 years and older from an Italian population-based cohort who were cognitively normal at an extensive assessment in 1999/2000 and underwent follow-up assessment in 2003/2004. Serum TSH was measured at baseline. Multinomial logistic models adjusted for sociodemographic and cardiovascular risk factors were used to investigate the association of serum TSH (both as a tertile and continuous log-transformed variable) with risk of incident MCI, AD and VaD diagnosed according to international criteria. Over 3.8 ± 0.7 years of follow-up, there were 149 incident MCI cases (77 with impairment of memory and 72 with impairment of nonmemory domains) and 86 incident dementia cases (53 with AD, 28 with VaD). No association between baseline TSH and risk of developing any MCI subtype or AD was found. The highest TSH tertile had a threefold higher increased risk of VaD (OR: 3.25, 95% CI: 1.01-10.77, p = 0.048) compared to the lowest tertile. Risk of VaD increased about 60% for each 1 SD increase in log-transformed TSH (OR: 1.61, 95% CI: 1.06-2.44, p = 0.025). In this elderly cohort, baseline TSH was not related to the risk of developing MCI or AD, but high TSH was associated with an increased risk of VaD. These results suggest further need for research using larger samples to examine the role of TSH as a predictor of VaD and the role of thyroid autoimmunity in vascular cognitive impairment.
ISSN:	1423-0003
DOI:	10.1159/000324522